1996
DOI: 10.1111/j.1432-1033.1996.0597u.x
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of the mRNA Cap‐Binding Ability of Human Eukaryotic Initiation Factor‐4E by Use of Recombinant Wild‐Type and Mutant Forms

Abstract: In order to identify the amino acid residues necessary for the selective recognition of the mRNA cap structure by human eukaryotic initiation factor-4E (eIF-4E), which plays a central role in the first step of mRNA translation, we prepared recombinant wild-type and fourteen mutant forms and compared their cap-binding abilities by affinity chromatography. By the direct expression of a synthetic gene encoding human eIF-4E as the soluble form in Escherichia coli and the application on a 7-methylguanosine-5'-triph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
36
0

Year Published

1998
1998
2014
2014

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 56 publications
(39 citation statements)
references
References 37 publications
3
36
0
Order By: Relevance
“…8); and (iii) the nuclease activity interacts very strongly with the 7-methyl GTP matrix, which partly resembles a methylated cap structure. This matrix is frequently used to affinity purify cap binding proteins (40). All of this evidence suggests that the 54-kDa fragment of PARN contains a cap-binding site.…”
Section: Discussionmentioning
confidence: 99%
“…8); and (iii) the nuclease activity interacts very strongly with the 7-methyl GTP matrix, which partly resembles a methylated cap structure. This matrix is frequently used to affinity purify cap binding proteins (40). All of this evidence suggests that the 54-kDa fragment of PARN contains a cap-binding site.…”
Section: Discussionmentioning
confidence: 99%
“…In vitro RNA-protein binding assays followed by RNA-protein EMSA were performed using recombinant P311, P311(Mut RRM ) and in vitro-produced 5ЈUTRs from several mRNAs, including those that encode TGF-␤s, GAPDH, ␤-actin, 18 S rRNA, and the protein product of the TGF-␤1 neighboring gene B9d2. All RNAs were confirmed to be effective in protein binding using as a control eIF4E, an established RNA-binding protein (41,42) (data not shown).…”
Section: P311 Binds To the 5јutrs Of Tgf-␤ Mrnas Through A Conserved mentioning
confidence: 97%
“…The cap binding assay was performed as previously described (Morino et al, 1996;Kang et al, 2005a). Expression of the recombinant proteins and purification of the proteins by m 7 GTP-Sepharose 4.B (Amersham Biosciences) were performed as described previously with minor modifications (Friedland et al, 1997).…”
Section: Cap Binding Assaysmentioning
confidence: 99%